JP2011509244A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011509244A5 JP2011509244A5 JP2010539934A JP2010539934A JP2011509244A5 JP 2011509244 A5 JP2011509244 A5 JP 2011509244A5 JP 2010539934 A JP2010539934 A JP 2010539934A JP 2010539934 A JP2010539934 A JP 2010539934A JP 2011509244 A5 JP2011509244 A5 JP 2011509244A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- specific targeting
- administration
- tumor
- brain tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1638107P | 2007-12-21 | 2007-12-21 | |
| PCT/US2008/087977 WO2009086284A1 (en) | 2007-12-21 | 2008-12-22 | Cd24 as a brain tumor stem cell marker and a diagnostic and therapeutic target in primary neaural and glial tumors of the brain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011509244A JP2011509244A (ja) | 2011-03-24 |
| JP2011509244A5 true JP2011509244A5 (https=) | 2012-05-17 |
Family
ID=40824698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010539934A Pending JP2011509244A (ja) | 2007-12-21 | 2008-12-22 | 脳の原発性神経腫瘍および神経膠腫における脳腫瘍幹細胞マーカーならびに診断および治療標的としてのｃｄ２４ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20110002846A1 (https=) |
| EP (1) | EP2231184A4 (https=) |
| JP (1) | JP2011509244A (https=) |
| CA (1) | CA2709380A1 (https=) |
| WO (1) | WO2009086284A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20201651T1 (hr) * | 2015-05-07 | 2020-12-25 | Oncoimmune, Inc. | Uporaba cd24 za snižavanje razina lipoproteina niske gustoće kolesterola |
| CN114381491A (zh) * | 2020-10-22 | 2022-04-22 | 复旦大学附属儿科医院 | 一种神经母细胞瘤相关的肿瘤细胞标志物及其应用 |
| CN116478999B (zh) * | 2023-01-16 | 2024-04-05 | 广西师范大学 | 免疫抑制分子cd24核酸适体的筛选及应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2556752C (en) * | 2004-02-23 | 2016-02-02 | Genentech, Inc. | Heterocyclic self-immolative linkers and conjugates |
| JP4942643B2 (ja) * | 2004-03-02 | 2012-05-30 | シアトル ジェネティックス， インコーポレイテッド | 部分的に付加された抗体およびそれらの結合体化方法 |
| EP1766017B1 (en) * | 2004-06-10 | 2015-01-21 | Viventia Bio Inc. | Tumor specific antibody |
| JP2008521828A (ja) * | 2004-11-29 | 2008-06-26 | シアトル ジェネティックス， インコーポレイテッド | 操作された抗体およびイムノコンジュゲート |
| CA2632675A1 (en) * | 2005-12-08 | 2007-07-05 | Lionel J. Coignet | Diagnostic and therapeutic strategies for conditions associated with the flj13639 gene |
| KR20080002341A (ko) * | 2006-06-30 | 2008-01-04 | 재단법인서울대학교산학협력재단 | Ｃｄ２４를 표적으로 하는 암 억제방법 |
| WO2009063461A1 (en) * | 2007-11-14 | 2009-05-22 | The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center | Methods of treating cancer using anti cd24 antibodies |
-
2008
- 2008-12-22 WO PCT/US2008/087977 patent/WO2009086284A1/en not_active Ceased
- 2008-12-22 EP EP20080868507 patent/EP2231184A4/en not_active Ceased
- 2008-12-22 CA CA2709380A patent/CA2709380A1/en not_active Abandoned
- 2008-12-22 JP JP2010539934A patent/JP2011509244A/ja active Pending
- 2008-12-22 US US12/809,491 patent/US20110002846A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025013502A (ja) | 悪性脳腫瘍における標的化粒子の浸透、分布および応答のための組成物及び方法 | |
| Chakravarty et al. | Clinical scale synthesis of intrinsically radiolabeled and cyclic RGD peptide functionalized 198Au nanoparticles for targeted cancer therapy | |
| JP6412918B2 (ja) | マルチモーダルシリカ系ナノ粒子 | |
| Ding et al. | Image guided biodistribution and pharmacokinetic studies of theranostics | |
| CN102395380B (zh) | 预靶向试剂盒、方法和其中使用的试剂 | |
| Maeda et al. | Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor | |
| JP2010017189A5 (https=) | ||
| CN102438656B (zh) | 预靶向试剂盒、方法和其中使用的试剂 | |
| Wang et al. | Nanotechnology in radiation oncology | |
| EP2522369A1 (en) | Pretargeting kit, method and agents used therein | |
| CN101511389A (zh) | 使用[3+2]叠氮化物-炔环加成的靶向成像和/或治疗 | |
| JP2013532126A5 (https=) | ||
| JP2010530745A (ja) | 腫瘍の画像化および／または処置のための微生物 | |
| JP2008515876A (ja) | イメージング及び治療用のイメージング及び治療のエンドキットにおけるシュタウディンガーライゲーションの使用 | |
| CA3174263A1 (en) | Immunotheranostic agent targeting mesenchymal stem cell-derived cancer cells and mesenchymal stem cell associated disease | |
| Truillet et al. | Synthesis and characterization of 89Zr-labeled ultrasmall nanoparticles | |
| JP2016528299A (ja) | ビタミンｂ１２および内因子を含む組成物およびその使用方法 | |
| Miyasato et al. | A path toward the clinical translation of nano‐based imaging contrast agents | |
| JP2011509244A5 (https=) | ||
| Fortin et al. | Labelling chemistry and characterization of [90Y/177Lu]-DOTA-ZHER2: 342-3 Affibody molecule, a candidate agent for locoregional treatment of urinary bladder carcinoma | |
| Zhang et al. | Bright semiconductor quantum dots shed new light on precision nanomedicine for various diseases | |
| GB2516882A (en) | Tumour-targeted theranostic | |
| Chen et al. | Bone-seeking albumin-nanomedicine for in vivo imaging and therapeutic monitoring | |
| WO2012047582A2 (en) | Compositions useful for target, detection, imaging and treatment, and methods of production and use thereof | |
| EP3946472A1 (en) | Targeting compounds for cancers selected from esophagus, pharynx and larynx, lung, brain, and intestines |